Cargando…

Correction to: Bispecific antibodies and dual-targeting CAR-T cells for multiple myeloma: latest updates from the 2023 ASCO annual meeting

Detalles Bibliográficos
Autores principales:	Hou, Jiangxue, Li, Yufu, Lin, Quande
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546715/ https://www.ncbi.nlm.nih.gov/pubmed/37789369 http://dx.doi.org/10.1186/s40164-023-00447-6

Ejemplares similares

Bispecific antibodies and dual-targeting CAR-T cells for multiple myeloma: latest updates from the 2023 ASCO annual meeting
por: Hou, Jiangxue, et al.
Publicado: (2023)

CD20 × CD3 bispecific antibodies for lymphoma therapy: latest updates from ASCO 2023 annual meeting
por: Liu, Xinyuan, et al.
Publicado: (2023)

BCMA-targeted CAR-T cell therapies in relapsed and/or refractory multiple myeloma: latest updates from 2023 ASCO Annual Meeting
por: Wu, James F., et al.
Publicado: (2023)

Bispecific antibodies targeting BCMA, GPRC5D, and FcRH5 for multiple myeloma therapy: latest updates from ASCO 2023 Annual Meeting
por: Zhao, Juanjuan, et al.
Publicado: (2023)

Bispecific antibody treatment of multiple myeloma: latest updates from the 2022 ASH annual meeting
por: Yin, Xuejiao, et al.
Publicado: (2023)

Bispecific T cell engagers targeting CD20/CD3 in B-cell lymphoma: latest updates from 2023 EHA annual meeting
por: Jin, Shenhe, et al.
Publicado: (2023)

New immunotherapy strategies for patients with sarcomas: highlights from the 2023 ASCO annual meeting
por: Roulleaux-Dugage, Matthieu, et al.
Publicado: (2023)

Novel ADCs and combination therapy in urothelial carcinoma: latest updates from the 2023 ASCO-GU Cancers Symposium
por: Yu, Jiazheng, et al.
Publicado: (2023)

Zukunft des ASCO Annual Meetings
por: Schmitz, Stephan
Publicado: (2020)

Genitourinary cancers updates: highlights from ASCO 2023
por: Qin, Qian, et al.
Publicado: (2023)

Recent updates on CAR T clinical trials for multiple myeloma
por: Lin, Quande, et al.
Publicado: (2019)

Highlights of ASCO 2023
por: Neugut, Alfred I, et al.
Publicado: (2023)

Update on squamous cell carcinoma of the head and neck: ASCO annual meeting 2017
por: Magnes, Teresa, et al.
Publicado: (2017)

Novel agents and clinical trials in castration-resistant prostate cancer: latest updates from 2023 ASCO-GU Cancers Symposium
por: Jiang, Yuanhong, et al.
Publicado: (2023)

CAR T cell therapy for T cell leukemia and lymphoma: latest updates from 2022 ASH Annual Meeting
por: Huang, Qiusha, et al.
Publicado: (2023)

Bispecific antibodies as monotherapy or in combinations for non-hodgkin B-cell lymphoma: latest updates from the American society of hematology 2022 annual meeting
por: Lin, Zhijuan, et al.
Publicado: (2023)

2019 ASCO Annual Meeting: Takeaways for Advanced Practitioners
por: Viale, Pamela Hallquist
Publicado: (2019)

2021 ASCO Annual Meeting: Takeaways for the Advanced Practitioner
por: Faiman, Beth
Publicado: (2021)

2022 ASCO Annual Meeting: Takeaways for the Advanced Practitioner
por: Faiman, Beth
Publicado: (2022)

Renal Cell Carcinoma Update: News from the AUA, EAU, and ASCO Annual Meetings 2011
por: Schrader, Andres Jan, et al.
Publicado: (2012)

Update on diffuse large B-cell lymphoma: highlights from the 2022 ASCO Annual Meeting
por: Qiu, Minghan, et al.
Publicado: (2022)

Therapeutic perspectives for adult soft tissue sarcoma—updates from the 2022 ASCO annual meeting
por: Yang, Jilong, et al.
Publicado: (2022)

2019 ASCO Annual Meeting Highlights for the Advanced Practitioner: Melanoma
Publicado: (2019)

Melanoma: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner
Publicado: (2021)

Melanoma: 2022 ASCO Annual Meeting Highlights for the Advanced Practitioner
Publicado: (2022)

Rituximab and new regimens for indolent lymphoma: a brief update from 2012 ASCO Annual Meeting
por: Zhao, Jiangning, et al.
Publicado: (2012)

A Focus on CAR T-Cell Therapy and Bispecific Antibodies in Multiple Myeloma
por: Catamero, Donna, et al.
Publicado: (2022)

2007 EORTC-NCI-ASCO Annual Meeting: Molecular Markers in Cancer
por: Lukan, C
Publicado: (2008)

2019 ASCO Annual Meeting Highlights for the Advanced Practitioner: Breast Cancer
Publicado: (2019)

2019 ASCO Annual Meeting Highlights for the Advanced Practitioner: Gynecologic Cancers
Publicado: (2019)

2019 ASCO Annual Meeting Highlights for the Advanced Practitioner: Issues in Oncology
Publicado: (2019)

2019 ASCO Annual Meeting Highlights for the Advanced Practitioner: Hematologic Malignancies
Publicado: (2019)

2019 ASCO Annual Meeting Highlights for the Advanced Practitioner: Prostate Cancer
Publicado: (2019)

2019 ASCO Annual Meeting Highlights for the Advanced Practitioner: Gastrointestinal Cancer
Publicado: (2019)

Issues in Oncology: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner
Publicado: (2021)

Gastrointestinal Cancers: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner
Publicado: (2021)

Breast Cancer: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner
Publicado: (2021)

Gynecologic Cancers: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner
Publicado: (2021)

Thoracic Cancer: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner
Publicado: (2021)

Hematologic Malignancies: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7r1cabb0ihljmp6o5e4vpcsnof